Atherosclerosis or lipoprotein-induced endothelial dysfunction: Potential mechanisms underlying reduction in EDRF/nitric oxide activity

Circulation

Volumn 85, Issue 5, 1992, Pages 1927-1938

  Flavahan, N A ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Guanine nucleotide regulatory protein; Hypercholesterolemia; Lipoproteins; Pertussis toxin; Point of View

Indexed keywords

ENDOTHELIUM DERIVED RELAXING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LIPOPROTEIN; NITRIC OXIDE; PERTUSSIS TOXIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CELL FUNCTION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HYPERCHOLESTEROLEMIA; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMAL; ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; GTP-BINDING PROTEINS; HUMAN; LIPOPROTEINS; NITRIC OXIDE; SIGNAL TRANSDUCTION; SUPPORT, U.S. GOV'T, P.H.S.; VIRULENCE FACTORS, BORDETELLA;

EID: 0026589006     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.85.5.1927     Document Type: Review

References (86)

1. Furchgott RF, Vanhoutte PM: Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007-2018
2. Moncada S, Radomski MW, Palmer RM: Endothelium-derived relaxing factor: Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988; 37:2495-2501
3. Ignarro LJ: Biosynthesis and metabolism of endothelium-derived nitric oxide. Ann Rev Pharmacol Toxicol 1990;30:535-560
4. Garg UC, Hassid A: Nitric oxide generating vasodilators and 8-bromo-cyclic GMP inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1990;83: 1774-1777
5. Gryglewski RJ, Botting RM, Vane JR: Mediators produced by the endothelium. Hypertension 1988;12:530-548
6. Bath PMW, Hassell DG, Gladwin AM, Palmer RMJ, Martin JF: Nitric oxide and prostacyclin: Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb 1991;11:254-260
7. Ross R: The pathogenesis of atherosclerosis: An update. N Engl J Med 1986;314:488-500
8. DiCorleto PE, Chisholm GM: Participation of the endothelium in the development of the atherosclerotic plaque. Prog Lipid Res 1986;25:365-374
9. Davies PF: Vascular cell interactions with special reference to the pathogenesis of atherosclerosis. Lab Invest 1986;55:5-24
10. Hansson GK, Bondjers G: Endothelial dysfunction and injury in atherosclerosis. Acta Med Scand 1987;(suppl 715):11-17
11. Werns SW, Walton JA, Hsai HH, Nabel EG, Sanz ML, Pitt B: Evidence of endothelial dysfunction in angiographically normal coronary arteries with coronary artery disease. Circulation 1989; 79:287-291
12. Harrison DG: From isolated vessels to the catheterization laboratory: Studies of endothelial function in the coronary circulation of humans. Circulation 1989;80:703-706
13. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikama Y, Ogawa H: Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Circulation 1990;81:482-490
14. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P: Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-497
15. Vanhoutte PM, Shimokawa H: Endothelium-derived relaxing factor and coronary vasospasm. Circulation 1989;80:1-9
16. Freiman PC, Mitchell GG, Heistad DD, Armstrong ML, Harrison DG: Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res 1986;58:783-789
17. Bossaller C, Habib GB, Yamamoto H, Williams C, Wells S, Henry PD: Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 1987;79: 170-174
18. Shimokawa H, Vanhoutte PM: Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res 1989;64:900-914
19. Cohen RA, Zitnay KM, Haudenschild CC, Cunningham LD: Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res 1988;63:903-910
20. Wines PA, Schmitz JM, Pfister SL, Clubb FJ Jr, Buja LM, Willerson JT, Campbell WB: Augmented vasoconstrictor responses to serotonin precede development of atherosclerosis in aorta of WHHL rabbit. Arteriosclerosis 1989;9:195-202
21. Komori K, Shimokawa H, Vanhoutte PM: Hypercholesterolemia impairs endothelium-dependent relaxations to aggregating platelets in porcine iliac arteries. J Vasc Surg 1989;10:318-325
22. Hayashi T, Naito M, Ishikawa T, Kuzuya M, Funaki C, Tateishi T, Asai K, Hidaka H, Kuzuya F: B-migrating very low density lipoprotein attenuates endothelium-dependent relaxation in rabbit atherosclerotic aortas. Blood Vessels 1989;26:290-299
23. Shimokawa H, Flavahan NA, Vanhoutte PM: Loss of endothelial pertussis toxin-sensitive G-protein function in atherosclerotic porcine coronary arteries. Circulation 1991;83:652-660
24. Shimokawa H, Flavahan NA, Vanhoutte PM: Natural course of the impairment of endothelium-dependent relaxations in regenerating porcine endothelial cells: Possible dysfunction of a pertussis toxin-sensitive G-protein. Circ Res 1990;65:740-753
25. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415
26. Katusic ZS, Vanhoutte PM: Superoxide anion is an endothelium-derived contracting factor. Am J Physiol 1989;257:H33-H37
27. 2-receptor antagonists inhibit endothelium-dependent contractions. Hypertension 1990;15:699-703
28. 2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension 1990;15:475-481
29. Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S: Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 1990;258:C408-C415
30. Minor RL, Myers PR, Guerra R, Bates JN, Harrison DG: Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 1990;86:2109-2116
31. Martin W, Viliani GM, Jothianandan D, Furchgott RF: Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985;232:708-716
32. Sreeharan N, Jayakody RL, Senarathe MPJ, Thomson ABR, Kappagoda CT: Endothelium-dependent relaxation and experimental atherosclerosis in the rabbit aorta. Can J Physiol Pharmacol 1986;64:1451-1453
33. Richard V, Tanner FC, Tschudi M, Luscher TF: Different activation of L-arginine pathway by bradykinin, serotonin and clonidine in coronary arteries. Am J Physiol 1990;259:H1433-H1439
34. Flavahan NA, Shimokawa H, Vanhoutte PM: Pertussis toxin inhibits endothelium-dependent relaxations to certain agonists in porcine coronary arteries. J Physiol 1989;408:549-560
35. Cowan CL, Cohen RA: Different mechanisms of relaxation to bradykinin and cromokalin are differentiated by potassium channel blockers (abstract). FASEB J 1991;5:A400
36. Nagao T, Vanhoutte PM: Endothelium-dependent relaxations resistant to nitro-L-arginine are mediated by endothelium-derived hyperpolarizations in porcine coronary arteries (abstract). FASEB J 1991;5:A1417
37. q class of G-proteins. Nature 1991;350:516-518
38. Birnbaumer L: G-proteins in signal transduction. Ann Rev Pharmacol Toxicol 1990;30:675-705
39. Neer EJ, Clapham DE: Roles of G-protein subunits in transmembrane signalling. Nature 1988;333:129-134
40. Freissmuth M, Casey PJ, Gilman AG: G-proteins control diverse pathways of transmembrane signalling. FASEB J 1989;3:2125-2131
41. Dolphin AC: Nucleotide binding proteins in health and disease. Trends Neurosci 1987;10:53-57
42. Flavahan NA, Vanhoutte PM: Pertussis toxin inhibits the endothelium-dependent relaxations to fluoride in canine coronary arteries. Eur J Pharmacol 1990;178:121-124
43. Flavahan NA, Shimokawa H, Vanhoutte PM: Inhibition of endothelium-dependent relaxation by phorbol myristate acetate: Role of a pertussis toxin-sensitive G-protein. J Pharmacol Exp Ther 1991;256:50-55
44. Cushing DJ, Soubouni MH, Brown GL, Mustafa SJ: Fluoride produces endothelium-dependent relaxation and endothelium-independent contraction in coronary artery. J Pharmacol Exp Ther 1990;254:28-38
45. Flavahan NA, Vanhoutte PM: G-proteins and endothelial responses. Blood Vessels 1990;27:218-229
46. Adams DJ, Barakeh J, Laskey R, Van Breeman C: Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J 1989;3:2389-2400
47. Voyno-Yasenetskaya TA, Tkachuk VA, Chernyova EG, Pancheuko MP, Grigorian GY, Vaurek RJ, Stewart JM, Ryan US: Guanine-nucleotide-dependent, pertussis toxin-insensitive regulation of phosphoinositide turnover by bradykinin in bovine pulmonary artery endothelial cells. FASEB J 1989;3:44-51
48. Kanamura K, Waga S, Tochio H, Nagatani K: The effect of atherosclerosis on endothelium-dependent relaxation in the aorta and intracranial arteries of rabbits. J Neurosurg 1989;70:793-795
49. Palmer RMJ, Ashton DS, Moncada S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-666
50. Sakuma I, Stuehr DJ, Gross SS, Nathan C, Levi R: Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci U S A 1988;85:8664-8667
51. Schmidt HHHW, Klein MM, Niromand F, Bohme E: Is arginine a physiological precursor of endothelium-derived nitric oxide? Eur J Pharmacol 1988;148:293-295
52. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43: 109-142
53. Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA: Arginine restores cholinergic relaxation of hypercholesterolemic rabbit aorta. Circulation 1991;83:1057-1062
54. Mugge A, Harrison DG: L-Arginine does not restore endothelial dysfunction in atherosclerotic rabbit aorta in vitro. Blood Vessels 1991;28:354-357
55. Drexler H, Zeiher AM: L-Arginine improves endothelial function in the coronary microcirculation of patients with hypercholesterolemia (abstract). Circulation 1991;84(suppl II):II-14
56. Henriksen T, Mahoney EM, Steinberg D: Interactions of lipoproteins with endothelial cells. Arteriosclerosis 1982;401:102-116
57. Morel DW, DiCorleto PE, Chisolm GM: Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984;4:357-364
58. Henriksen T, Mahoney EM, Steinberg D: Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci U S A 1981;78: 6499-6503
59. Jacobs M, Plane F, Bruckdorfer KR: Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta. Br J Pharmacol 1990;100:21-26
60. Tomita T, Ezaki M, Miwa M, Nakamura K, Inoue Y: Rapid and reversible inhibition by low density lipoprotein of the endothelium-dependent relaxation to hemostatic substances in porcine coronary arteries. Circ Res 1990;66:18-27
61. Galle J, Mulsch A, Busse R, Bassenge E: Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler Thromb 1991;11: 198-203
62. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD: Impairment of endothelium-dependent relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990;344:160-162
63. Yokoyama M, Hirata K, Miyake R, Akita H, Ishikawa Y, Fukuzaki H: Lysophosphatidylcholine: Essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low-density lipoprotein. Biochem Biophys Res Commun 1990;168:301-308
64. Simon BC, Cunningham LD, Cohen RA: Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 1990;86:75-79
65. Steinbrecher U: Role of superoxide in endothelial-cell modification of low density lipoproteins. Biochim Biophys Acta 1988;959: 20-30
66. Rubanyi GM, Vanhoutte PM: Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986; 250:H822-H827
67. Gryglewski RJ, Palmer RMJ, Moncada S: Superoxide anion is involved in the breakdown of endothelium-derived relaxing factor. Nature 1986;320:454-456
68. Tanner FC, Noll G, Boulanger CM, Lüscher TF: Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries: Role of scavenger receptor and endothelium-derived nitric oxide. Circulation 1991;83:2012-2020
69. Flavahan NA, Mooney T: Lysolecithin inhibits a G protein-dependent pathway in porcine endothelial cells (abstract). FASEB J 1991;5:A1729
70. Saito T, Wolf A, Menon NK, Saeed M, Bing RJ: Lysolecithins as endothelium-dependent vascular smooth muscle relaxants that differ from endothelium-derived relaxing factor (nitric oxide). Proc Natl Acad Sci U S A 1988;85:8246-8250
71. Quinn PJ: Membrane lipid phase behaviour and lipid-protein interactions. Biochem Soc Trans 1990;18:133-136
72. Henis YI: Lateral mobility measurement of cell surface components: Applications for molecular pharmacology. Trends Pharmacol Sci 1989;10:95-98
73. Moscana-Amir E, Henis YI, Yechiel E, Barenholz Y, Sokolovsky M: Role of lipids in age-related changes in the properties of muscarinic receptors in cultured rat heart myocytes. Biochemistry 1986;25:8118-8124
74. Moscana-Amir E, Henis YI, Sokolovsky M: Aging of rat heart myocytes disrupts muscarinic receptor coupling that leads to inhibition of cAMP accumulation and alters the pathway of muscarinic-stimulated phosphoinositide hydrolysis. Biochemistry 1989;28:7130-7137
75. Houslay M, Gordon LM: The activity of adenylate cyclase is regulated by the nature of its lipid environment. Curr Top Memb Transp 1983;18:179-231
76. Houslay MD, Palmer RW: Lysophosphatidylcholines can modulate the activity of the glucagon-stimulated adenylate cyclase from rat liver plasma membranes. Biochem J 1979;178:217-221
77. Spiegel AM, Backlund PS, Butrynski JE, Jones TLZ, Simonds WF: The G-protein connection: Molecular basis of membrane association. Trends Biochem Sci 1991;16:338-341
78. Goldstein JL, Brown MS: Regulation of the mevalonate pathway. Nature 1990;343:425-430
79. Haigh LS, Leatherman GF, O'Hara DS, Smith TW, Galper JB: Effects of low density lipoproteins and mevinolin on cholesterol content and muscarinic cholinergic responsiveness in cultured chick atrial cells. J Biol Chem 1988;263:15608-15618
80. Quinn MT, Kondratenko N, Parthasarathy S: Analysis of the monocyte chemotactic response to lysophosphatidylcholine: Role of lysophospholipase C. Biochim Biophys Acta 1991;1082:293-302
81. Katada T, Gilman AG, Watanabe Y, Bauer S, Jakobs KH: Protein kinase C phosphorylates the inhibitory guanine-nucleotide binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. Eur J Biochem 1985;151: 431-437
82. i-mediated inhibition of human platelet adenylate cyclase. FEBS Lett 1985;192:23-27
83. Flavahan NA, Shimokawa H, Vanhoutte PM: Inhibition of endothelium-dependent relaxation by phorbol myristate acetate in canine coronary arteries: Role of a pertussis toxin-sensitive G-protein. J Pharmacol Exp Ther 1991;256:50-55
84. Verbeuren TJ, Jordaens FH, VanHove CE, Van Hoydonck AE, Herman AG: Release and vascular activity of endothelium-derived relaxing factor in atherosclerotic rabbit aorta. Eur J Pharmacol 1990;191:173-184
85. Galle J, Bassenge E, Busse R: Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ Res 1990;66:1287-1293
86. Tagawa H, Tomoike H, Nakamura M: Putative mechanisms of the impairment of endothelium-dependent relaxation of the aorta with atheromatous plaque in heritable hyperlipidemic rabbits. Circ Res 1991;68:330-337